This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Medgaea Japan Co., Ltd., Medgaea Life Sciences Ltd., South Product Ltd.. Active years: 2020-2024.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2020-2024
Title: The Innovative Contributions of Masahiko Iha
Introduction: Masahiko Iha, an inventive mind hailing from Okinawa, Japan, has made notable strides in the field of pharmaceuticals through his innovative work. With two patents to his name, Iha has developed unique compositions aimed at improving health outcomes and enhancing the absorption of beneficial compounds in the body.
Latest Patents: Among Masahiko Iha's most recent patents is the "Carbohydrate composition as pharmaceutical ingredient and use thereof." This invention consists of a carbohydrate composition that includes fucose, glucuronic acid, galactose, and arabinose, formulated in specific weight percentages. Fucose is present at 45.5% to 76% by weight, glucuronic acid at 11% to 19% by weight, galactose at 4.5% to 14.5% by weight, and arabinose at 5.5% to 18% by weight. Additionally, his patent titled "Fucoidan preparation, zinc-bound fucoidan and use thereof" introduces a novel technique for enhancing the absorption of fucoidan, utilizing a preparation that combines fucoidan with zinc, aimed at elevating the beneficial effects of fucoidan in the body.
Career Highlights: Masahiko Iha has had a significant career, notably affiliated with companies such as Medgaea Japan Co., Ltd. and Medgaea Life Sciences Ltd. His work has been pivotal in developing pharmaceutical ingredients that can lead to advancements in medical treatments and health supplements.
Collaborations: Throughout his career, Iha has collaborated with esteemed professionals in the field, including Chang-Jer Wu and Bo-Rui Chen. These partnerships have bolstered the innovative efforts in research and development of pharmaceutical compositions, contributing to enhanced therapeutic applications.
Conclusion: Masahiko Iha's contributions to the field of pharmaceutical innovations reflect a commitment to improving health through scientific exploration. His patents serve as a testament to his inventive spirit and dedication to advancing medical science. As he continues to work on groundbreaking projects, the implications of his research hold promise for future innovations in pharmaceuticals.